Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Angiography | 14 | 2015 | 1432 | 1.450 |
Why?
|
Pulmonary Veins | 10 | 2015 | 743 | 1.220 |
Why?
|
Heart Atria | 9 | 2013 | 1345 | 0.800 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 4 | 2023 | 225 | 0.700 |
Why?
|
Salicylates | 2 | 2017 | 127 | 0.660 |
Why?
|
Atrial Fibrillation | 15 | 2018 | 5127 | 0.640 |
Why?
|
Magnetic Resonance Imaging, Cine | 10 | 2019 | 1050 | 0.620 |
Why?
|
Spironolactone | 1 | 2021 | 412 | 0.560 |
Why?
|
Myocardial Perfusion Imaging | 5 | 2021 | 575 | 0.540 |
Why?
|
Catheter Ablation | 7 | 2015 | 2751 | 0.500 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2013 | 174 | 0.470 |
Why?
|
Phlebography | 1 | 2015 | 326 | 0.450 |
Why?
|
Contrast Media | 12 | 2016 | 5307 | 0.440 |
Why?
|
Magnetic Resonance Imaging | 22 | 2023 | 36426 | 0.430 |
Why?
|
Gadolinium DTPA | 5 | 2012 | 823 | 0.410 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2015 | 694 | 0.410 |
Why?
|
Atrial Flutter | 2 | 2004 | 252 | 0.380 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2019 | 2009 | 0.370 |
Why?
|
Personnel, Hospital | 1 | 2013 | 285 | 0.370 |
Why?
|
Atrial Function, Left | 2 | 2011 | 185 | 0.360 |
Why?
|
Imaging, Three-Dimensional | 11 | 2023 | 4062 | 0.350 |
Why?
|
Image Enhancement | 10 | 2014 | 2884 | 0.340 |
Why?
|
Image Interpretation, Computer-Assisted | 7 | 2014 | 3359 | 0.340 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2004 | 774 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 4 | 2021 | 2244 | 0.330 |
Why?
|
Cicatrix | 4 | 2013 | 798 | 0.330 |
Why?
|
Head and Neck Neoplasms | 2 | 2014 | 2894 | 0.320 |
Why?
|
Overweight | 2 | 2017 | 2417 | 0.310 |
Why?
|
Coronary Vessels | 4 | 2010 | 3096 | 0.310 |
Why?
|
Immunosuppressive Agents | 5 | 2015 | 4176 | 0.310 |
Why?
|
Microscopic Polyangiitis | 2 | 2023 | 46 | 0.300 |
Why?
|
Coronary Artery Disease | 11 | 2021 | 6403 | 0.300 |
Why?
|
Artifacts | 6 | 2020 | 1911 | 0.300 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2014 | 4024 | 0.290 |
Why?
|
Losartan | 1 | 2008 | 265 | 0.280 |
Why?
|
Ventricular Function, Left | 8 | 2021 | 3879 | 0.270 |
Why?
|
Electrocardiography | 12 | 2021 | 6377 | 0.270 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2273 | 0.270 |
Why?
|
Cerebrovascular Disorders | 1 | 2013 | 1474 | 0.260 |
Why?
|
Coronary Disease | 7 | 2022 | 5914 | 0.260 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 431 | 0.260 |
Why?
|
Cerebrovascular Circulation | 2 | 2013 | 2727 | 0.250 |
Why?
|
Myocardial Contraction | 2 | 2011 | 1515 | 0.250 |
Why?
|
Amiodarone | 2 | 2004 | 217 | 0.250 |
Why?
|
Exercise Test | 4 | 2019 | 2127 | 0.250 |
Why?
|
Outpatients | 3 | 2015 | 1597 | 0.250 |
Why?
|
Coronary Thrombosis | 1 | 2008 | 440 | 0.240 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2005 | 64 | 0.240 |
Why?
|
Heart | 5 | 2020 | 4404 | 0.240 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 5 | 2019 | 1068 | 0.240 |
Why?
|
Plaque, Atherosclerotic | 1 | 2016 | 1532 | 0.240 |
Why?
|
Middle Aged | 61 | 2023 | 220921 | 0.240 |
Why?
|
Radiation Dosage | 1 | 2013 | 1958 | 0.240 |
Why?
|
Pulmonary Eosinophilia | 1 | 2004 | 78 | 0.220 |
Why?
|
Churg-Strauss Syndrome | 1 | 2004 | 75 | 0.220 |
Why?
|
Leukotriene Antagonists | 1 | 2004 | 124 | 0.220 |
Why?
|
Predictive Value of Tests | 14 | 2021 | 15266 | 0.220 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2645 | 0.220 |
Why?
|
Cardiac Volume | 1 | 2004 | 197 | 0.210 |
Why?
|
Radiographic Image Enhancement | 2 | 2007 | 876 | 0.210 |
Why?
|
Male | 72 | 2023 | 360846 | 0.210 |
Why?
|
Acetates | 1 | 2004 | 321 | 0.210 |
Why?
|
Lymph Nodes | 1 | 2014 | 3465 | 0.200 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2019 | 2118 | 0.200 |
Why?
|
B-Lymphocytes | 2 | 2015 | 4758 | 0.200 |
Why?
|
Angina Pectoris | 2 | 2019 | 959 | 0.200 |
Why?
|
Aged | 43 | 2023 | 169310 | 0.190 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6345 | 0.190 |
Why?
|
Obesity | 5 | 2016 | 12947 | 0.190 |
Why?
|
Patient Identification Systems | 1 | 2001 | 75 | 0.190 |
Why?
|
Echocardiography, Doppler | 3 | 2019 | 897 | 0.190 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2013 | 2791 | 0.180 |
Why?
|
Coronary Angiography | 9 | 2021 | 4471 | 0.180 |
Why?
|
Female | 68 | 2021 | 392705 | 0.180 |
Why?
|
Defibrillators, Implantable | 4 | 2015 | 1490 | 0.180 |
Why?
|
Humans | 90 | 2023 | 761596 | 0.180 |
Why?
|
Sensitivity and Specificity | 11 | 2014 | 14665 | 0.180 |
Why?
|
Gadolinium | 4 | 2013 | 960 | 0.170 |
Why?
|
Blood Flow Velocity | 3 | 2013 | 1371 | 0.170 |
Why?
|
Aortic Valve Insufficiency | 2 | 2019 | 576 | 0.170 |
Why?
|
Myocardium | 4 | 2018 | 4725 | 0.170 |
Why?
|
Leg Injuries | 1 | 2021 | 179 | 0.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3246 | 0.170 |
Why?
|
Myocardial Ischemia | 2 | 2013 | 2113 | 0.160 |
Why?
|
Soccer | 1 | 2021 | 142 | 0.160 |
Why?
|
Reproducibility of Results | 11 | 2019 | 20100 | 0.160 |
Why?
|
Glucose Transporter Type 1 | 1 | 2019 | 186 | 0.160 |
Why?
|
Antihypertensive Agents | 1 | 2008 | 2024 | 0.160 |
Why?
|
Quinolines | 1 | 2004 | 765 | 0.160 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2012 | 535 | 0.160 |
Why?
|
Cardiomyopathies | 3 | 2021 | 1964 | 0.160 |
Why?
|
Kidney Diseases | 3 | 2022 | 2091 | 0.150 |
Why?
|
Ventricular Remodeling | 2 | 2019 | 1267 | 0.140 |
Why?
|
Stroke Volume | 5 | 2021 | 5496 | 0.140 |
Why?
|
Lectins | 1 | 2019 | 491 | 0.140 |
Why?
|
Stents | 2 | 2008 | 3179 | 0.140 |
Why?
|
Cardiac-Gated Imaging Techniques | 3 | 2013 | 139 | 0.140 |
Why?
|
Diabetic Angiopathies | 2 | 2012 | 803 | 0.140 |
Why?
|
Treatment Outcome | 17 | 2019 | 64685 | 0.140 |
Why?
|
Heart Failure | 1 | 2021 | 11671 | 0.140 |
Why?
|
Adult | 38 | 2023 | 221210 | 0.130 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2018 | 851 | 0.130 |
Why?
|
Inflammation | 1 | 2016 | 10774 | 0.130 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2008 | 2751 | 0.130 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 267 | 0.130 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2011 | 1310 | 0.130 |
Why?
|
Coronary Stenosis | 1 | 2021 | 794 | 0.130 |
Why?
|
Sarcoidosis | 1 | 2021 | 521 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 8 | 2015 | 20568 | 0.130 |
Why?
|
Tachycardia, Sinus | 1 | 2015 | 42 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2013 | 12149 | 0.120 |
Why?
|
Respiratory-Gated Imaging Techniques | 2 | 2012 | 75 | 0.120 |
Why?
|
Mycophenolic Acid | 2 | 2022 | 349 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2020 | 9001 | 0.120 |
Why?
|
Mitral Valve Prolapse | 1 | 2016 | 212 | 0.120 |
Why?
|
Prospective Studies | 15 | 2023 | 54423 | 0.120 |
Why?
|
Tachycardia, Ventricular | 2 | 2015 | 1304 | 0.120 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2019 | 2155 | 0.120 |
Why?
|
Meglumine | 2 | 2013 | 144 | 0.110 |
Why?
|
Pericardium | 1 | 2018 | 675 | 0.110 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2011 | 578 | 0.110 |
Why?
|
Molecular Imaging | 1 | 2020 | 815 | 0.110 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2013 | 75 | 0.110 |
Why?
|
Fats | 1 | 2014 | 99 | 0.110 |
Why?
|
Coronary Aneurysm | 2 | 2008 | 232 | 0.110 |
Why?
|
Heart Valves | 1 | 2015 | 284 | 0.110 |
Why?
|
Genetic Association Studies | 3 | 2019 | 2735 | 0.110 |
Why?
|
Hypertension | 3 | 2011 | 8540 | 0.110 |
Why?
|
Chest Pain | 2 | 2012 | 1091 | 0.110 |
Why?
|
Lymphocyte Depletion | 1 | 2015 | 602 | 0.110 |
Why?
|
Allergy and Immunology | 1 | 2014 | 176 | 0.100 |
Why?
|
Radiopharmaceuticals | 3 | 2019 | 2650 | 0.100 |
Why?
|
Multivariate Analysis | 4 | 2015 | 12059 | 0.100 |
Why?
|
Motion | 2 | 2013 | 779 | 0.100 |
Why?
|
Time Factors | 10 | 2015 | 39969 | 0.100 |
Why?
|
Supine Position | 2 | 2019 | 205 | 0.100 |
Why?
|
Alzheimer Disease | 1 | 2013 | 8601 | 0.100 |
Why?
|
Remission Induction | 2 | 2015 | 2397 | 0.100 |
Why?
|
Recurrence | 4 | 2015 | 8466 | 0.090 |
Why?
|
Prediabetic State | 1 | 2017 | 545 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2021 | 1796 | 0.090 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2013 | 638 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 4 | 2015 | 6484 | 0.090 |
Why?
|
Athletic Injuries | 1 | 2021 | 1216 | 0.090 |
Why?
|
Organometallic Compounds | 2 | 2013 | 647 | 0.090 |
Why?
|
Hemoptysis | 1 | 2012 | 152 | 0.090 |
Why?
|
Acute Coronary Syndrome | 2 | 2015 | 2190 | 0.090 |
Why?
|
Nephrology | 1 | 2014 | 263 | 0.090 |
Why?
|
Cholesterol, HDL | 2 | 2022 | 1814 | 0.090 |
Why?
|
Pyrophosphatases | 1 | 2011 | 142 | 0.090 |
Why?
|
General Practice | 1 | 2011 | 97 | 0.090 |
Why?
|
Mortality | 1 | 2001 | 2902 | 0.090 |
Why?
|
Boston | 6 | 2016 | 9327 | 0.090 |
Why?
|
Coronary Circulation | 2 | 2013 | 1569 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 2 | 2008 | 1007 | 0.090 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2011 | 201 | 0.090 |
Why?
|
Databases, Factual | 3 | 2016 | 7968 | 0.090 |
Why?
|
Electric Countershock | 1 | 2013 | 533 | 0.090 |
Why?
|
Troponin T | 1 | 2015 | 780 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2015 | 1186 | 0.080 |
Why?
|
Bone Marrow Transplantation | 2 | 2007 | 2693 | 0.080 |
Why?
|
Echocardiography | 2 | 2013 | 4989 | 0.080 |
Why?
|
Switzerland | 2 | 2014 | 324 | 0.080 |
Why?
|
Aortic Valve | 1 | 2019 | 1955 | 0.080 |
Why?
|
Pilot Projects | 5 | 2019 | 8633 | 0.080 |
Why?
|
Vascular System Injuries | 1 | 2013 | 246 | 0.080 |
Why?
|
Azathioprine | 1 | 2010 | 354 | 0.080 |
Why?
|
Prognosis | 6 | 2023 | 29629 | 0.080 |
Why?
|
Algorithms | 7 | 2018 | 14033 | 0.080 |
Why?
|
Glomerular Filtration Rate | 3 | 2012 | 2178 | 0.080 |
Why?
|
Echocardiography, Transesophageal | 1 | 2015 | 1086 | 0.080 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2011 | 557 | 0.080 |
Why?
|
Primary Prevention | 2 | 2013 | 1186 | 0.080 |
Why?
|
Retrospective Studies | 13 | 2019 | 80647 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2011 | 705 | 0.080 |
Why?
|
Mitral Valve Insufficiency | 2 | 2010 | 1400 | 0.080 |
Why?
|
Albuminuria | 1 | 2012 | 658 | 0.080 |
Why?
|
Rheumatology | 1 | 2014 | 615 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2014 | 58984 | 0.070 |
Why?
|
Observer Variation | 3 | 2019 | 2606 | 0.070 |
Why?
|
Magnetics | 1 | 2011 | 599 | 0.070 |
Why?
|
Myocardial Infarction | 3 | 2015 | 11461 | 0.070 |
Why?
|
Cyclophosphamide | 2 | 2010 | 2220 | 0.070 |
Why?
|
Severity of Illness Index | 9 | 2019 | 15843 | 0.070 |
Why?
|
Glutamic Acid | 1 | 2013 | 1176 | 0.070 |
Why?
|
Fatty Liver | 1 | 2014 | 790 | 0.070 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2850 | 0.070 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2010 | 366 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4347 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2015 | 1027 | 0.070 |
Why?
|
Internal Medicine | 1 | 2014 | 1051 | 0.070 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2007 | 108 | 0.070 |
Why?
|
Respiratory Mechanics | 1 | 2011 | 699 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1892 | 0.070 |
Why?
|
Aortic Diseases | 1 | 2013 | 735 | 0.070 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2006 | 141 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 17904 | 0.070 |
Why?
|
Diastole | 2 | 2011 | 782 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2018 | 3313 | 0.070 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2008 | 261 | 0.070 |
Why?
|
Brain | 1 | 2013 | 27121 | 0.070 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2915 | 0.060 |
Why?
|
Risk Factors | 11 | 2017 | 74213 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2011 | 555 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2013 | 15936 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2017 | 12341 | 0.060 |
Why?
|
Feasibility Studies | 4 | 2019 | 5247 | 0.060 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2006 | 241 | 0.060 |
Why?
|
Aorta | 1 | 2013 | 2041 | 0.060 |
Why?
|
Positron-Emission Tomography | 2 | 2019 | 6484 | 0.060 |
Why?
|
Italy | 3 | 2011 | 842 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2013 | 1555 | 0.060 |
Why?
|
Thallium | 1 | 2004 | 100 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2015 | 2220 | 0.060 |
Why?
|
Diabetes Complications | 1 | 2011 | 1315 | 0.060 |
Why?
|
Incidental Findings | 1 | 2009 | 697 | 0.060 |
Why?
|
Lung Diseases | 2 | 2012 | 1909 | 0.060 |
Why?
|
Cardiovascular Diseases | 4 | 2017 | 15502 | 0.060 |
Why?
|
Prone Position | 1 | 2005 | 196 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 877 | 0.060 |
Why?
|
Body Size | 1 | 2006 | 463 | 0.060 |
Why?
|
Registries | 2 | 2015 | 8225 | 0.060 |
Why?
|
Myocardial Revascularization | 1 | 2007 | 790 | 0.060 |
Why?
|
Sulfides | 1 | 2004 | 169 | 0.050 |
Why?
|
Heart Rate | 1 | 2015 | 4195 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2014 | 6312 | 0.050 |
Why?
|
Risk Assessment | 8 | 2019 | 23996 | 0.050 |
Why?
|
Heart Conduction System | 1 | 2008 | 1007 | 0.050 |
Why?
|
Triglycerides | 1 | 2011 | 2461 | 0.050 |
Why?
|
Acute Disease | 3 | 2008 | 7237 | 0.050 |
Why?
|
Blood Glucose | 1 | 2017 | 6391 | 0.050 |
Why?
|
Cyclopropanes | 1 | 2004 | 432 | 0.050 |
Why?
|
Movement | 2 | 2011 | 1478 | 0.050 |
Why?
|
Case-Control Studies | 7 | 2019 | 22176 | 0.050 |
Why?
|
Young Adult | 9 | 2021 | 59260 | 0.050 |
Why?
|
Postoperative Care | 1 | 2009 | 1468 | 0.050 |
Why?
|
Bradycardia | 1 | 2003 | 299 | 0.050 |
Why?
|
Social Security | 1 | 2001 | 101 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 289 | 0.050 |
Why?
|
Radiosurgery | 1 | 2010 | 1342 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2898 | 0.050 |
Why?
|
Antirheumatic Agents | 1 | 2010 | 1373 | 0.050 |
Why?
|
Apolipoprotein A-I | 1 | 2022 | 299 | 0.040 |
Why?
|
Laser Therapy | 1 | 2007 | 1092 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2011 | 2775 | 0.040 |
Why?
|
Cardiology | 1 | 2011 | 1656 | 0.040 |
Why?
|
Incidence | 4 | 2011 | 21355 | 0.040 |
Why?
|
Follow-Up Studies | 7 | 2015 | 39106 | 0.040 |
Why?
|
Hemorrhage | 1 | 2012 | 3424 | 0.040 |
Why?
|
Coronary Vessel Anomalies | 1 | 2003 | 307 | 0.040 |
Why?
|
Radionuclide Imaging | 3 | 2013 | 1972 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2003 | 537 | 0.040 |
Why?
|
Genotype | 4 | 2019 | 12990 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1626 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8002 | 0.040 |
Why?
|
Bariatric Surgery | 1 | 2009 | 992 | 0.040 |
Why?
|
Linear Models | 2 | 2011 | 5872 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2004 | 3415 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2013 | 15633 | 0.040 |
Why?
|
Purines | 1 | 2021 | 607 | 0.040 |
Why?
|
Logistic Models | 3 | 2011 | 13255 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7528 | 0.040 |
Why?
|
Coronary Artery Bypass | 2 | 2007 | 2188 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2004 | 1302 | 0.040 |
Why?
|
Weight Loss | 1 | 2009 | 2684 | 0.040 |
Why?
|
Biological Transport | 1 | 2022 | 2091 | 0.040 |
Why?
|
Lipoproteins | 1 | 2022 | 881 | 0.030 |
Why?
|
Adolescent | 7 | 2023 | 88326 | 0.030 |
Why?
|
Cognition | 1 | 2014 | 6992 | 0.030 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 26129 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2011 | 3964 | 0.030 |
Why?
|
Kidney | 1 | 2012 | 7048 | 0.030 |
Why?
|
Patient Positioning | 1 | 2019 | 326 | 0.030 |
Why?
|
Heart Diseases | 1 | 2009 | 2781 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5841 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 2010 | 2217 | 0.030 |
Why?
|
Recovery of Function | 2 | 2019 | 2979 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2007 | 3807 | 0.030 |
Why?
|
Chronic Disease | 3 | 2019 | 9319 | 0.030 |
Why?
|
Blood Sedimentation | 1 | 2014 | 235 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9177 | 0.030 |
Why?
|
Equipment Design | 2 | 2011 | 3511 | 0.030 |
Why?
|
Blood Pressure | 1 | 2008 | 8481 | 0.030 |
Why?
|
Placebos | 1 | 2017 | 1667 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2905 | 0.030 |
Why?
|
Respiration | 2 | 2011 | 1656 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2013 | 12463 | 0.030 |
Why?
|
Phenotype | 3 | 2019 | 16592 | 0.020 |
Why?
|
Water | 1 | 2018 | 1411 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2013 | 6815 | 0.020 |
Why?
|
Genetic Testing | 2 | 2019 | 3537 | 0.020 |
Why?
|
Hong Kong | 1 | 2011 | 166 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2007 | 3407 | 0.020 |
Why?
|
Pyrazoles | 1 | 2021 | 2009 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10766 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3156 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11076 | 0.020 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2011 | 122 | 0.020 |
Why?
|
Survival Analysis | 1 | 2003 | 10090 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 577 | 0.020 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2010 | 42 | 0.020 |
Why?
|
Glomerulonephritis | 1 | 2012 | 331 | 0.020 |
Why?
|
Cohort Studies | 3 | 2011 | 41495 | 0.020 |
Why?
|
Utilization Review | 1 | 2011 | 382 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2018 | 2526 | 0.020 |
Why?
|
Prednisolone | 1 | 2010 | 326 | 0.020 |
Why?
|
Lung | 2 | 2007 | 10002 | 0.020 |
Why?
|
Internet | 1 | 2001 | 3093 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 413 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2049 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2010 | 335 | 0.020 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1553 | 0.020 |
Why?
|
Methylprednisolone | 1 | 2010 | 385 | 0.020 |
Why?
|
Odds Ratio | 2 | 2011 | 9647 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 847 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4740 | 0.020 |
Why?
|
Survival Rate | 2 | 2013 | 12723 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6864 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1574 | 0.020 |
Why?
|
Proteinuria | 1 | 2010 | 607 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2013 | 1204 | 0.020 |
Why?
|
Antimalarials | 1 | 2014 | 907 | 0.020 |
Why?
|
Systole | 1 | 2010 | 936 | 0.020 |
Why?
|
Triiodobenzoic Acids | 1 | 2007 | 123 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3306 | 0.020 |
Why?
|
Child | 4 | 2023 | 80158 | 0.020 |
Why?
|
Age Factors | 1 | 2004 | 18399 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2011 | 973 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3578 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1913 | 0.020 |
Why?
|
Pleural Diseases | 1 | 2007 | 137 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 1998 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2011 | 836 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4948 | 0.020 |
Why?
|
Health Resources | 1 | 2012 | 935 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2013 | 2115 | 0.020 |
Why?
|
Aortography | 1 | 2007 | 421 | 0.020 |
Why?
|
Hematoma | 1 | 2010 | 767 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2011 | 2079 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1881 | 0.020 |
Why?
|
Cerebral Infarction | 1 | 2010 | 983 | 0.020 |
Why?
|
Asthma | 1 | 2004 | 6234 | 0.020 |
Why?
|
Sodium Chloride | 1 | 2007 | 587 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2011 | 1192 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2014 | 1670 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1814 | 0.010 |
Why?
|
Gene Frequency | 1 | 2011 | 3606 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2010 | 1475 | 0.010 |
Why?
|
Reference Values | 1 | 2011 | 4920 | 0.010 |
Why?
|
Genome-Wide Association Study | 2 | 2013 | 12690 | 0.010 |
Why?
|
Carotid Stenosis | 1 | 2010 | 860 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 1241 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2643 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2007 | 2115 | 0.010 |
Why?
|
Body Mass Index | 2 | 2011 | 12953 | 0.010 |
Why?
|
Hospitals | 1 | 2015 | 3883 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9610 | 0.010 |
Why?
|
Patient Selection | 1 | 2013 | 4244 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2010 | 2161 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42232 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4243 | 0.010 |
Why?
|
United States | 2 | 2013 | 72340 | 0.010 |
Why?
|
Rest | 1 | 2004 | 918 | 0.010 |
Why?
|
Computational Biology | 1 | 2011 | 3517 | 0.010 |
Why?
|
Health Care Costs | 1 | 2012 | 3242 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2007 | 1161 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2007 | 1927 | 0.010 |
Why?
|
Calcinosis | 1 | 2007 | 1469 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6426 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 2358 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9420 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6228 | 0.010 |
Why?
|
Insulin | 1 | 2011 | 6597 | 0.010 |
Why?
|
Electroencephalography | 1 | 2012 | 6237 | 0.010 |
Why?
|
Models, Statistical | 1 | 2011 | 5079 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30053 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7879 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15733 | 0.010 |
Why?
|
Quality of Life | 1 | 2011 | 13367 | 0.010 |
Why?
|